Abraxane®

Active substance

paclitaxel

Holder

Celgene

Status

Closed

Indication

in combination with gemcitabine for the first line treatment of metastatic adenocarcinoma of the pancreas

Public documents

Approbation

Information for the patient

Informed consent

Last update

02/05/2017

Last updated on 13/02/2024